2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$44.39+$0.02 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT- $9.2BMarket Cap
- 191.14%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$44.39+$0.02 (+0.05%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.37 | ||
Change | +$0.02 (+0.05%) | ||
Open | $44.85 | ||
High | $45.12 | ||
Low | $44.08 | ||
Previous Close | $44.35 | ||
Volume | 846,584 | ||
30-Day Average Volume | 1,059,045 | ||
1-Week Change | 6.10% | ||
1-Month Change | 12.24% | ||
1-Year Change | 191.14% | ||
3-Year Change | 115.60% | ||
5-Year Change | 465.22% | ||
Fundamentals | |||
Shares Outstanding | 206.6M | ||
Total Assets | $852.5M | ||
Market Cap | $9.2B | ||
Enterprise Value | $8.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$153.2M | ||
Free Cash Flow | -$124.4M | ||
EBIT | -$153.2M | ||
EBITDA | -$153.1M | ||
Net Working Capital | $734.1M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -55 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -59 | ||
PEG | 17 | ||
Price/Free Cash Flow | -74 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue